2007 NSTI Nanotechnology Conference and Trade Show - Nanotech 2007 - 10th Annual

Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen

A. Remes
University of Pittsburgh, US

immunotherapy, anti-cancer agent, Finn

The invention provides a method of activating a signaling pathway and/or killing a cancer cell using a receptor that is similar to or is a T cell receptor.

Back to Program

Sessions Sunday Monday Tuesday Wednesday Thursday Authors Keywords

Nanotech 2007 Conference Program Abstract


Names, and logos of other organizations are the property of those organizations and not of NSTI.
This event is not open to the general public and NSTI reserves the right to refuse admission and participation to any individual.